On the 19th, LG Chem announced it had signed a Memorandum of understanding (MOU) with BR Pharm, a regenerative medicine technology research and manufacturing company, for the development and approval of its PN (polynucleotide) skin booster 'HP Vitaran' in China.

BR Pharm's 'Vitaran', which LG Chem introduced to the Korean market in September this year, is a PN skin booster medical device created from purified DNA extracted from the reproductive cells of salmon fish.

PN suppresses cytokines that cause skin inflammation and promotes skin tissue regeneration by proliferating fibroblasts.

In a clinical trial for 'Vitaran Eye' that involved 250 Koreans, the treatment sig